TCR-based cancer immunotherapy biotech (UK)
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 75 | New buy | 15,000,000 | $13,491,130 | 0.0% |
| Steve Cohen / Point72 | 75 | Added +27% | 1,257,897 | $38,101,700 | 0.0% |
| Louis Bacon / Moore | 52 | Trimmed -30% | 193,045 | $5,847,333 | 0.1% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.